CeraVe Developed with Dermatologists Healing

PETROLATUM TOPICAL HUMAN OTC DRUG

CeraVe Developed with Dermatologists Healing is an FDA drug label for the active ingredient PETROLATUM manufactured by L'Oreal USA Products Inc. administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231231.

Generic name
PETROLATUM
Manufacturer
L'Oreal USA Products Inc.
Product type
HUMAN OTC DRUG
Route
TOPICAL
Dosage form
N/A
NDC
49967-500
Application
M016
Label effective
20231231

Active ingredients

Active ingredient Petrolatum 46.5%

Indications & Usage

Uses • temporarily protects and helps relieve chafed, chapped or cracked skin temporarily protects minor: ● cuts ● scrapes ● burns helps protect from the drying effects of wind and cold weather

Dosage & Administration

Directions apply as needed

Contraindications

Not available.

Warnings

Warnings For external use only

Adverse Reactions

Not available.

More products with the same ingredient

PETROLATUM

BALMEX MULTI-PURPOSE

Randob Labs,Ltd. View label

CeraVe Developed with Dermatologists Baby Healing

L'Oreal USA Products Inc. View label

Healquick Tattoo Balm

Unit Dose, Ltd. View label

Petrolatum

Greenbrier International, Inc. View label

Petrolatum

Greenbrier International, Inc. View label

Petrolatum Jelly

NEW PRIDE CORP View label

Resurfix Plus

Topiderm, Inc. View label